Back in 2000, my company, Gene Logic, had begun to develop a database of human surgical tissue samples analyzed with Affymetrix expression microarrays. We sold these data to major pharmaceutical companies that used it to identify and prioritize new drug targets. At that time, the excitement around genomics was in full swing. We were very enthusiastic about how this knowledge of disease could be used for new pharmaceutical and diagnostics applications.
Advertisement
Survey Series
Institutions
For Advertisers
Reviving the Dead
What started as a wild idea in 2000 languished, until a chance meeting in Washington gave an opportunity to jumpstart a new business.
|
|||||||||
|
|||||||||
|
